XML 40 R29.htm IDEA: XBRL DOCUMENT v3.19.1
Related Parties Transactions (Tables)
 3 Months Ended
Mar. 31, 2019
Related Party Transactions [Abstract]  
Schedule of related party transactions
Name of entity or Individual   Relationship with the Company and its subsidiaries
BioFirst Corporation (the "BioFirst")   Entity controlled by controlling beneficiary shareholder of Yuangene
BioFirst (Australia) Pty Ltd. (the "BioFirst (Australia)")   100% owned by BioFirst; Entity controlled by controlling beneficiary shareholder of YuanGene
Lion Arts Promotion Inc. (the "LION")   Controlling shareholder of BioLite Inc.
LionGene Corporation (the "LionGene")   Shareholder of the Company; entity controlled by controlling beneficiary shareholder of YuanGene
Rgene Corporation (the "Rgene")   Shareholder of the Company; entity controlled by controlling beneficiary shareholder of Yuangene
Yuangene Corporation (the "Yuangene")   Controlling beneficiary shareholder of the Company
AsianGene Corporation (the "AsianGene")   Shareholder; entity controlled by controlling beneficiary shareholder of Yuangene
Keypoint Technology Ltd. (the "Keypoint')   The Chairman of Keypoint is Eugene Jiang's mother.
Yoshinobu Odaira (the "Odaira")   Director of the Company
GenePharm Inc. (the "GenePharm")   Mr. George Lee, the Director and Chairman of Biokey, is the Chairman of Genepharm.
Mr. Tsung-Shann Jiang, Ms. Shu-Ling Jiang and Mr. Eugene Jiang (the "Jiangs")  

Mr. Tsung-Shann Jiang, the controlling beneficiary shareholder of the Company and Rgene, the chairman and CEO of the BioLite Inc. and the President and a member of board of directors of BioFirst,

Ms. Shu-Ling Jiang, Mr. Tsung-Shann Jiang's wife, is a member of board of directors of the Company and the chairman of LION and BioFirst.

Mr. Eugene Jiang is Mr. and Ms. Jiang's son. Mr. Eugene Jiang is the chairman, and majority shareholder of the Company and a member of board of directors of BioLite Inc.
Schedule of accounts receivable related parties

   March 31,   December 31, 
   2019   2018 
GenePharm Inc.  $142,265   $     - 
Total  $142,265   $- 
Schedule of due from related parties
   March 31,   December 31, 
   2019   2018 
Rgene Corporation  $17,550   $19,477 
BioFirst (Australia)  $40,675   $40,000 
Total  $58,225   $59,477 
Schedule of amount due to related party

   March 31,   December 31, 
   2019   2018 
Lion Arts Promotion Inc.  $64,964   $65,495 
LionGene Corporation   430,940    458,348 
BioFirst Corporation   6,248,105    6,428,643 
AsianGene Corporation   160,000    160,000 
YuanGene Corporation   92,690    92,690 
The Jiangs   598,085    539,920 
Total  $7,594,784   $7,745,096